Harmjan R. Vos

3.8k total citations
58 papers, 1.8k citations indexed

About

Harmjan R. Vos is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Harmjan R. Vos has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cell Biology. Recurrent topics in Harmjan R. Vos's work include RNA Research and Splicing (10 papers), RNA modifications and cancer (9 papers) and RNA and protein synthesis mechanisms (7 papers). Harmjan R. Vos is often cited by papers focused on RNA Research and Splicing (10 papers), RNA modifications and cancer (9 papers) and RNA and protein synthesis mechanisms (7 papers). Harmjan R. Vos collaborates with scholars based in Netherlands, United Kingdom and United States. Harmjan R. Vos's co-authors include Boudewijn Burgering, Tobias B. Dansen, Albert J. R. Heck, Joost W. Gouw, Martijn W. H. Pinkse, Xiaogang Zhang, Willem Stoorvogel, Hendrik A. Raué, Alex W. Faber and Shabaz Mohammed and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Harmjan R. Vos

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harmjan R. Vos Netherlands 24 1.3k 252 192 188 176 58 1.8k
Yusuke Saito Japan 24 1.3k 1.0× 244 1.0× 149 0.8× 283 1.5× 184 1.0× 119 2.1k
Kyunggon Kim South Korea 24 961 0.7× 143 0.6× 109 0.6× 155 0.8× 144 0.8× 94 1.6k
Demetrios T. Braddock United States 22 2.1k 1.6× 286 1.1× 160 0.8× 584 3.1× 389 2.2× 53 2.8k
Brian M. Balgley United States 25 1.3k 1.0× 204 0.8× 107 0.6× 269 1.4× 94 0.5× 35 2.4k
Andrew Pierce United Kingdom 23 1.3k 1.0× 423 1.7× 76 0.4× 270 1.4× 59 0.3× 69 2.2k
Kevin Hakala United States 20 809 0.6× 207 0.8× 118 0.6× 147 0.8× 71 0.4× 31 1.2k
Sandip Chatterjee India 18 806 0.6× 226 0.9× 101 0.5× 92 0.5× 313 1.8× 63 1.6k
Andrew J. Andrews United States 26 2.4k 1.9× 566 2.2× 224 1.2× 354 1.9× 106 0.6× 48 3.1k
Joan Chang United Kingdom 20 683 0.5× 329 1.3× 82 0.4× 222 1.2× 116 0.7× 33 1.5k
David Banach United States 11 1.3k 1.0× 281 1.1× 181 0.9× 121 0.6× 129 0.7× 15 1.8k

Countries citing papers authored by Harmjan R. Vos

Since Specialization
Citations

This map shows the geographic impact of Harmjan R. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmjan R. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmjan R. Vos more than expected).

Fields of papers citing papers by Harmjan R. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harmjan R. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmjan R. Vos. The network helps show where Harmjan R. Vos may publish in the future.

Co-authorship network of co-authors of Harmjan R. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Harmjan R. Vos. A scholar is included among the top collaborators of Harmjan R. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harmjan R. Vos. Harmjan R. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reinhard, Nathalie R., et al.. (2026). Calcineurin-NFAT-DSCR1.4 signaling as druggable axis in Gαq-R183Q–driven capillary malformations. Angiogenesis. 29(2). 16–16.
2.
Vliem, Marjolein J., Joo Yong Sim, Kenta Terai, et al.. (2025). E-cadherin mechanotransduction activates EGFR-ERK signaling in epithelial monolayers by inducing ADAM-mediated ligand shedding. Science Signaling. 18(886). eadr7926–eadr7926. 1 indexed citations
3.
Pablo, Yolanda de, Isaac Canals, Harmjan R. Vos, et al.. (2024). Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease. Glia. 73(1). 57–79. 2 indexed citations
4.
Schene, Imre F., Marisa I. Mendes, Desirée E.C. Smith, et al.. (2024). Isoleucine-to-valine substitutions support cellular physiology during isoleucine deprivation. Nucleic Acids Research. 53(1). 1 indexed citations
5.
Hubers, Lowiek M., et al.. (2024). Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. Frontiers in Immunology. 14. 1251134–1251134. 8 indexed citations
6.
Wang, Maojie, Harmjan R. Vos, Edwin C.A. Stigter, et al.. (2023). Metabolic rewiring in keratinocytes by miR‐31‐5p identifies therapeutic intervention for psoriasis. EMBO Molecular Medicine. 15(4). e15674–e15674. 13 indexed citations
7.
Hernández-Quiles, Miguel, Miesje M. van der Stoel, J. van den Burg, et al.. (2023). Early adipogenesis is repressed through the newly identified FHL2-NFAT5 signaling complex. Cellular Signalling. 104. 110587–110587. 4 indexed citations
8.
Liv, Nalan, Mark Opdam, Rutger C.C. Hengeveld, et al.. (2022). FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer. Cell Reports. 39(1). 110584–110584. 7 indexed citations
9.
Roosmalen, Markus J. van, Nizar Hami, Ingrid Verlaan-Klink, et al.. (2020). Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity. Molecular Cancer Research. 18(4). 537–548. 11 indexed citations
10.
Zhang, Xiaogang, Harmjan R. Vos, Weiyang Tao, & Willem Stoorvogel. (2020). Proteomic Profiling of Two Distinct Populations of Extracellular Vesicles Isolated from Human Seminal Plasma. International Journal of Molecular Sciences. 21(21). 7957–7957. 31 indexed citations
11.
Fleskens, Veerle, Carlos M. Minutti, Xingmei Wu, et al.. (2019). Nemo-like Kinase Drives Foxp3 Stability and Is Critical for Maintenance of Immune Tolerance by Regulatory T Cells. Cell Reports. 26(13). 3600–3612.e6. 39 indexed citations
12.
Hubers, Lowiek M., Harmjan R. Vos, Alex R. Schuurman, et al.. (2017). Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 67(4). 728–735. 132 indexed citations
13.
Tessadori, Federico, Jacques C. Giltay, Jane A. Hurst, et al.. (2017). Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control. Nature Genetics. 49(11). 1642–1646. 34 indexed citations
14.
Spruijt, Cornelia G., Martijn S. Luijsterburg, Roberta Menafra, et al.. (2016). ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage. Cell Reports. 17(3). 783–798. 85 indexed citations
15.
Visscher, Marieke, Sasha De Henau, Mattheus H. E. Wildschut, et al.. (2016). Proteome-wide Changes in Protein Turnover Rates in C. elegans Models of Longevity and Age-Related Disease. Cell Reports. 16(11). 3041–3051. 49 indexed citations
16.
Putker, Marrit, Harmjan R. Vos, Hesther de Ruiter, et al.. (2014). Evolutionary Acquisition of Cysteines Determines FOXO Paralog-Specific Redox Signaling. Antioxidants and Redox Signaling. 22(1). 15–28. 55 indexed citations
17.
Macůrek, Libor, et al.. (2010). Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition. Oncogene. 29(15). 2281–2291. 117 indexed citations
18.
Boer, Paulo de, Harmjan R. Vos, Alex W. Faber, J. Chris Vos, & Hendrik A. Raué. (2006). Rrp5p, a trans-acting factor in yeast ribosome biogenesis, is an RNA-binding protein with a pronounced preference for U-rich sequences. RNA. 12(2). 263–271. 23 indexed citations
19.
20.
Venema, Jaap, Harmjan R. Vos, Alex W. Faber, Walther J. van Venrooij, & Hendrik A. Raué. (2000). Yeast Rrp9p is an evolutionarily conserved U3 snoRNP protein essential for early pre-rRNA processing cleavages and requires box C for its association. RNA. 6(11). 1660–1671. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Saito Breakdown of academic impact, for papers by Kyunggon Kim Breakdown of academic impact, for papers by Demetrios T. Braddock Breakdown of academic impact, for papers by Brian M. Balgley Breakdown of academic impact, for papers by Andrew Pierce Breakdown of academic impact, for papers by Kevin Hakala Breakdown of academic impact, for papers by Sandip Chatterjee Breakdown of academic impact, for papers by Andrew J. Andrews Breakdown of academic impact, for papers by Joan Chang Breakdown of academic impact, for papers by David Banach
Rankless by CCL
2026